mRNA Vaccine Insights
The rapid development of mRNA vaccines, like those from Pfizer and Moderna, was a groundbreaking achievement, taking mere weeks to create the genetic recipe for the spike protein. Clinical trials demonstrated a remarkable efficacy rate of 95%, revealing that the vaccine effectively preloaded the body with antibodies to combat COVID-19. This swift response to the pandemic set new expectations for vaccine transmission protection, significantly influencing public health messaging.In this clip
From this podcast

Commune with Jeff Krasno
557. "Daddy, did the vaccine work?"
Related Questions